A
Allison Hall
Researcher at Duke University
Publications - 54
Citations - 1177
Allison Hall is an academic researcher from Duke University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 12, co-authored 42 publications receiving 869 citations. Previous affiliations of Allison Hall include Durham University.
Papers
More filters
Journal ArticleDOI
RNA interference using boranophosphate siRNAs: structure–activity relationships
TL;DR: It is demonstrated that boranophosphate si RNAs are consistently more effective than siRNAs with the widely used phosphorothioate modification and are promising candidates for an RNAi-based therapeutic.
Journal ArticleDOI
RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells
TL;DR: Reducing E6 and E7 expression is sufficient to cause HeLa cells to become senescent and is demonstrated to cause morphological and biochemical changes characteristic of cellular senescence.
Journal ArticleDOI
High potency silencing by single-stranded boranophosphate siRNA
Allison Hall,Jing Wan,April Spesock,Zinaida A. Sergueeva,Barbara Ramsay Shaw,Kenneth A. Alexander +5 more
TL;DR: It is demonstrated that boranophosphate-modified ss-siRNA can silence gene expression as well as native ds-si RNA, suggesting thatboranoph phosphate- modified ss-SIRNAs should be investigated as a potential new class of therapeutic agents.
Journal ArticleDOI
Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.
Kristy M. Bialas,Takayuki Tanaka,Dollnovan Tran,Dollnovan Tran,Valerie Varner,Eduardo Cisneros De La Rosa,Flavia Chiuppesi,Felix Wussow,Lisa M. Kattenhorn,Sheila Cummings Sm Macri,Erika L. Kunz,Judy A. Estroff,Jennifer L. Kirchherr,Yujuan Yue,Qihua Fan,Michael Lauck,David H. O’Connor,Allison Hall,Alvarez Xavier,Don J. Diamond,Peter A. Barry,Amitinder Kaur,Amitinder Kaur,Sallie R. Permar +23 more
TL;DR: Maternal CD4+ T-cell immunity during primary rhCMV infection is important for controlling maternal viremia and inducing protective immune responses that prevent severe CMV-associated fetal disease.
Journal ArticleDOI
Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database
Cecilia T. Ong,Brittany M. Campbell,Samantha M. Thomas,Rachel A. Greenup,Jennifer K. Plichta,Laura H. Rosenberger,Jeremy Force,Allison Hall,Terry Hyslop,E. Shelley Hwang,Oluwadamilola M. Fayanju +10 more
TL;DR: Metaplastic breast cancer patients had worse survival than non-MBC patients, independent of receptor status, suggesting that MBC may confer an additional survival disadvantage.